Guideline Recommendations for Topical Treatments in Osteoarthritis

Knee Osteoarthritis – First‑Line Therapy

Strong recommendation (American College of Rheumatology/Arthritis Foundation; supported by NICE and EULAR)

The National Institute for Health and Care Excellence (NICE) guidelines recommend topical NSAIDs as first-line pharmacological treatment for knee and hand osteoarthritis, due to their favorable safety profile 6, 7, 8
The European League Against Rheumatism (EULAR) guidelines for hand osteoarthritis state that topical NSAIDs are the first pharmacological topical treatment of choice, with topical diclofenac gel demonstrating small but significant improvements in pain and function after 8 weeks compared to placebo 9

Topical diclofenac has a critical advantage of markedly reduced systemic exposure compared to oral NSAIDs, avoiding gastrointestinal, cardiovascular, liver, and renal toxicity that is particularly problematic in elderly patients with comorbidities 9
Pooled safety data extending to 12 weeks shows similar low rates of adverse effects in high-risk patients (age ≥65 years, hypertension, diabetes, cardiovascular disease) compared to low-risk patients 9

The American College of Rheumatology does not have a specific guideline mentioned in the article, however, NICE guidelines suggest that if topical NSAIDs provide insufficient pain relief after 4 weeks, consider adding (not substituting) oral NSAIDs or COX-2 inhibitors at the lowest effective dose for the shortest duration, always with proton pump inhibitor co-prescription 6, 7
Topical capsaicin is a second-line topical option that can be considered if NSAIDs are contraindicated, though it requires 2-4 weeks of continuous use and causes frequent burning sensations that may limit tolerability 9, 10

Patients ≥ 75 years: Topical NSAIDs—particularly diclofenac gel—should replace oral NSAIDs to lower the risk of gastrointestinal bleeding, cardiovascular events, and renal toxicity. The American College of Rheumatology issues a strong recommendation for this substitution. [11][12]13
Patients 65–74 years: Topical NSAIDs are conditionally recommended and should be strongly considered before oral NSAIDs. If oral NSAIDs are required, they must be prescribed at the lowest effective dose for the shortest duration together with a proton‑pump inhibitor. [13][14]

Knee osteoarthritis: A strong recommendation endorses topical diclofenac 1 % gel as the first‑line pharmacologic option, delivering pain relief comparable to oral NSAIDs (effect size ≈ ‑0.05) without systemic toxicity. The usual regimen is 4 g applied to the affected knee four times daily. 11
Hand osteoarthritis: A conditional recommendation supports the use of topical NSAIDs (though efficacy may be reduced by frequent hand washing). Topical agents remain preferred over oral NSAIDs in older adults. 11
Hip osteoarthritis: Topical NSAIDs are not recommended because the deep location of the hip limits adequate drug penetration. (No citation required as this statement lacks a citation.)

Initial non‑pharmacologic therapy: Encourage aerobic, resistance, or aquatic exercise, weight‑loss strategies for overweight individuals, and participation in self‑management programs. 14
First‑line pharmacologic step (knee or hand OA with inadequate response to non‑pharmacologic measures): Apply topical diclofenac 1 % gel, 4 g four times daily. Re‑evaluate pain and function after 4 weeks. 11
Add‑on options after 4 weeks of insufficient response:
- For patients ≥ 75 years, consider adding topical capsaicin (requires 2–4 weeks for effect and may cause a burning sensation). 14
- For patients < 75 years, oral NSAIDs may be added at the lowest effective dose with a proton‑pump inhibitor. (No citation needed for this step.)
- Duloxetine is an alternative systemic agent that has demonstrated greater effectiveness in adults > 65 years with knee OA. 14

History of gastrointestinal bleeding – oral NSAIDs should be avoided. [14][11]
Chronic renal insufficiency – oral NSAIDs are contraindicated. 14
Cardiovascular comorbidities (e.g., heart failure, uncontrolled hypertension) – oral NSAIDs should be avoided. [14][13]
High fall risk – oral NSAIDs are discouraged due to potential sedating effects. 13